Cancer Immunotherapy Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Cancer immunotherapy is a therapy that utilizes part of patients' immune system to fight against cancer. The therapy stimulates the person's own immune system to attack the cancer cells. There are different types of immunotherapy that includes monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines and other non-specific immunotherapies. Monoclonal antibodies are man-made antibodies that are used in treating cancer as they recognize specific part of a cancer cell and attacks on it. In recent years, many different types of immunotherapy are being studied for its use against cancer.

MARKET DYNAMICS

The cancer immunotherapy market is expected to grow exponentially in the forecast period owing to the factors such as growing prevalence of cancer, rising adoption of advanced cancer therapies and growing Research and development activities in the cancer immunotherapy field. Furthermore, development of new products coupled with large number of FDA approvals, is anticipated to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Cancer Immunotherapy Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the cancer immunotherapy market with detailed market segmentation by therapy, application, end user, and geography. The global cancer immunotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cancer immunotherapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global cancer immunotherapy market is segmented on the basis of therapy, application and end user. Based on therapy, the market is classified as monoclonal antibodies, immune checkpoint inhibitors, immune system modulators, and cancer vaccines. Based on application, the market is classified as lung cancer, colorectal cancer, breast cancer, prostate cancer, melanoma, head and neck cancer, ovarian cancer, others. On the basis of end user the cancer immunotherapy market is classified as hospitals, ambulatory surgery centers, cancer research centers, specialty clinics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer immunotherapy market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer immunotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cancer immunotherapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cancer immunotherapy market in these regions.

MARKET PLAYERS

The reports cover key developments in the cancer immunotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cancer immunotherapy market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer immunotherapy market in the global market. Below mentioned is the list of few companies engaged in the cancer immunotherapy market.

The report also includes the profiles of key cancer immunotherapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  F. Hoffmann-La Roche AG
•  Advaxis Inc.
•  Merck & Co., Inc.
•  Eli Lilly and Company
•  Bristol-Myers Squibb Company
•  Pfizer Inc.
•  Novartis AG
•  Bayer AG
•  Immunomedics Inc.
•  Astrazeneca plc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Cancer Immunotherapy Report Scope